Range Low Price High Price Comment
30 days $142.01 $161.00 Wednesday, 27th Mar 2024 ASND stock ended at $148.44. This is 1.01% less than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 2.53% from a day low at $146.93 to a day high of $150.65.
90 days $119.03 $161.00
52 weeks $64.33 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2023-05-03 $86.51 $94.44 $85.00 $91.56 1 651 049
2023-05-02 $88.07 $89.40 $85.73 $85.99 2 624 144
2023-05-01 $76.21 $87.00 $76.02 $86.74 4 720 776
2023-04-28 $76.50 $76.50 $66.03 $69.96 3 292 471
2023-04-27 $76.44 $77.56 $74.87 $76.98 951 352
2023-04-26 $78.30 $78.93 $76.12 $76.44 741 985
2023-04-25 $79.97 $80.26 $77.78 $78.36 569 014
2023-04-24 $81.14 $81.14 $78.57 $79.77 489 752
2023-04-21 $83.35 $83.75 $80.83 $80.93 535 554
2023-04-20 $82.98 $84.45 $81.85 $83.03 322 902
2023-04-19 $81.16 $83.54 $79.05 $83.03 653 482
2023-04-18 $82.91 $82.91 $79.89 $81.28 713 219
2023-04-17 $81.25 $84.00 $81.00 $82.76 549 887
2023-04-14 $82.57 $83.89 $80.20 $81.17 689 163
2023-04-13 $82.05 $83.13 $79.86 $82.57 795 931
2023-04-12 $80.60 $84.07 $80.26 $81.97 1 469 546
2023-04-11 $74.12 $81.52 $74.12 $80.18 1 563 835
2023-04-10 $72.69 $74.36 $71.33 $73.92 645 895
2023-04-06 $70.66 $73.14 $69.44 $72.69 3 358 005
2023-04-05 $69.28 $72.99 $68.60 $71.19 1 997 584
2023-04-04 $71.01 $72.56 $67.00 $71.43 2 278 416
2023-04-03 $67.12 $77.77 $64.33 $72.83 8 061 474
2023-03-31 $109.05 $109.28 $106.19 $107.22 345 368
2023-03-30 $111.23 $111.23 $107.38 $108.56 259 526
2023-03-29 $110.53 $111.51 $108.04 $110.59 134 795
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT